2 recruiting, 1 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 2, Completed 1 |
Follow Apollo Therapeutics Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis Camoteskimab, Placebo - Atopic Dermatitis, Atopic | Phase 2 | Recruiting | Apollo Therapeutics Ltd | 280 | 2026-05-28 | 2026-08-28 |
| A Trial of "APL-9796'' in Adults With Pulmonary Hypertension APL-9796 - Pulmonary Arterial Hypertension | Phase 2 | Recruiting | Apollo Therapeutics Ltd | 48 | 2025-04-09 | 2026-05-11 |
| A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis Camoteskimab, Placebo - Atopic Dermatitis, Atopic | Phase 2 | Completed | Apollo Therapeutics Ltd | 62 | 2024-05-01 | 2025-09-18 |
Dermatitis (2) · Dermatitis, Atopic (2) · Eczema (2) · Skin Diseases (2) · Hypertension, Pulmonary (1) · Pulmonary Arterial Hypertension (1)
Canada (2) · United States (2) · Bulgaria (1) · Czechia (1) · Germany (1) · Hungary (1) · Poland (1) · Spain (1) · United Kingdom (1)